 | Blueprint Medicines Corporation | |||
| NMS : BPMC || Location: United States | ||||
$92.29+1.68 (+1.85%) |
0.78 M | 89.19 - 94.67 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 4.372 M |
| March 15, 2024 | 5.151 M |
| Feb. 29, 2024 | 5.136 M |
| Feb. 15, 2024 | 4.628 M |
| Jan. 31, 2024 | 4.600 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -2.08 | -1.82 | 12.53% |
| 09/30/2023 | -2.41 | -2.20 | 8.88% |
| 06/30/2023 | -2.59 | -2.19 | 15.46% |
| 03/31/2023 | -2.72 | -2.15 | 21.05% |
| 12/31/2022 | -2.70 | -2.65 | 1.95% |
BPMC Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 61.232M | Shares Float | 60.548M |
| Short Float | 4.372M | Market Cap | 5651.10M |
| Institution ownership | 0.00% | Insider ownership | 0.846% |
| Earnings Date | 05/02/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -8.37 | Forward EPS | -2.78 |